|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.22 USD | +2.27% |
|
-1.88% | +51.20% |
| 07-29 | Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says | MT |
| 07-29 | UBS Adjusts Price Target on Centene to $70 From $61, Maintains Neutral Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 70.67 | +13.58% | 18 | ||||||
| 475.23 | +14.68% | 26 | ||||||
| 449.1 | +19.49% | 21 | ||||||
| 343.38 | +23.05% | 24 | ||||||
| 407.83 | +12.08% | 23 | ||||||
| 209.12 | +6.9% | 17 | ||||||
| 24.62 | +65.76% | 13 | ||||||
| 34 | +9.22% | 11 | ||||||
| 4.583 | +9.91% | 3 | ||||||
| 513.33 | +43.39% | 3 | ||||||
| Average | 253.18 | +21.81% | 16 | ||||||
| Weighted average by Cap. | 421.67 | +16.16% | 24 |
- Stock Market
- Stocks
- CNC Stock
- Sector Centene Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
